Global Cardiovascular Repair and Reconstruction Market – Industry Trends and Forecast to 2029

Global Cardiovascular Repair and Reconstruction Market, Ву Туре (Неаrt Vаlvе Rераіr, Саrdіоvаѕсulаr Grаftѕ, аnd Саrdіоvаѕсulаr Раtсhеѕ ), Аррlісаtіоn (Ваbіеѕ, аnd Аdultѕ) - Industry Trends and Forecast to 2029

Market Analysis and Size

According to Grand View Research, the global cardiovascular repair and reconstruction devices market is estimated to reach USD 4,481.5 million by 2025. Over the forecast period, an increase in congenital heart defects (CHDs) and the availability of technologically enhanced cardiovascular valves, grafts, and patches are likely to drive growth.

Data Bridge Market Research analyses that the cardiovascular repair and reconstruction market which was USD 3.72 billion in 2021, would rocket up to USD 6.06 billion by 2029, and is expected to undergo a CAGR of 6.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Heart disorders such as congenital heart disease, coronary artery disease, and arrhythmias are examples of cardiovascular diseases. Blockages in blood arteries can cause chest discomfort and heart attacks. Men are more likely than women to have chest discomfort as a symptom of cardiovascular disease, whereas women may experience symptoms such as excessive exhaustion, shortness of breath, and nausea. Blockages in arteries and veins are removed using cardiovascular reconstruction devices.

Cardiovascular Repair and Reconstruction Market Dynamics

Drivers

• Rise in cardiac diseases

According to the American Heart Association, cardiovascular diseases (CVDs) were a leading cause of death in the United States in 2015, accounting for approximately 800,000 fatalities. In the United States, about 85.6 million people are affected by the effects of a stroke or another type of CVD. It is one of the leading causes of death in the world. CVDs claimed the lives of almost 17.7 million individuals in 2015, accounting for roughly 31% of all fatalities worldwide. Mild CHD is becoming more common in the United States. Over a quarter of babies with CHD develop catastrophic CHD in their first year, which requires surgery or medication to cure. As a result, the cardiovascular repair and reconstruction market is expected to increase significantly throughout the forecast period.

• Technological advancements

New technologically advanced products, product designs, raw material procurement, raw material production, clinical evaluation, preservation solutions, and preservation procedures have all been produced. Consider the usage of ePTFE in the fabrication of cardiovascular patches by Gore Medical. ePTFE patches are strengthening the cardiovascular repair and reconstruction industry as their use for various cardiovascular repair devices grows.

• Improvement of cryopreservation procedures

Cryopreservation procedures that are technologically improved also contribute to the growth of the cardiovascular repair devices market. They aid in preserving raw materials collected from animal tissues for a longer period of time, which is critical in extending their life cycle. These technological advancements are helping to drive market growth by increasing demand for cardiovascular grafts and patches.

Opportunities

Tissue valve demand has increased since the introduction of transcatheter valves. TAVI (Transcatheter Aortic Valve Implantation) or TAVR (Transcatheter Aortic Valve Replacement) is an FDA-approved procedure for treating symptomatic aortic stenosis with a heart valve replacement. The TAVR market is dominated by established players like Edwards Lifesciences and Medtronic. In addition, JenaValve, a German business, successfully enrolled for the CE mark study for the next-generation JenaValve Pericardial TAVR system in April 2018, and is planning a restricted launch in a select European areas and countries compatible with the CE mark in the coming quarters. In the next years, new companies with innovative technologies will significantly enhance market growth.

Restraints/Challenges

The danger of skin infections is predicted to impede market expansion throughout the forecast period. The high cost of cardiovascular repair and reconstruction products and a lack of understanding about microbe-derived items are predicted to hinder market expansion over the forecast period of 2022 to 2029.

This cardiovascular repair and reconstruction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiovascular repair and reconstruction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Cardiovascular Repair and Reconstruction Market

During the first half of 2020, the COVID-19 had a negative impact on the worldwide cardiovascular surgical devices business. The World Health Organization recognized the emergence of healthcare with the outbreak of Covid-19 (WHO). Furthermore, the governments instituted a nationwide lockdown and a flight restriction. Furthermore, cardiac surgery activities were halted and postponed due to the unexpected shutdown, causing the market to fall. However, the market has grown significantly in the aftermath of the pandemic. Furthermore, heart surgery usage has increased, and the market has grown at the fastest rate. With the arrival of the year 2021, market shares are predicted to increase on average.

Recent Development

• In October 2020, GE Healthcare got FDA 510k clearance for its ultra-edition bundle of vivid cardiovascular ultrasound devices, which includes new AI-based capabilities that allow doctors to consistently obtain faster, more reproducible assessments.

Global Cardiovascular Repair and Reconstruction Market Scope

The cardiovascular repair and reconstruction market is segmented on the basis of product, raw material and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Heart Valve Repair
• Cardiovascular Grafts
• Endovascular stent graft
• Hemodialysis access graft
• Peripheral vascular graft
• Cardiovascular Patches

 Application

• Cardiac repair patches
• Atrial septal defect
• Common atrium
• Defects of the endocardial cushion
• Ventricular septal defect
• Tetralogy of Fallot
• Suture bleeding
• Vascular Repair Patches
• Carotid endarterectomy
• Anomalous connection of the pulmonary veins
• Transportation of the great vessels
• Reconstruction of the portal and superior mesenteric veins
• Others

Raw Material

• Synthetic patches
• Biological patches

Cardiovascular Repair and Reconstruction Market Regional Analysis/Insights

The cardiovascular repair and reconstruction market is analysed and market size insights and trends are provided by country, product, raw material and application as referenced above.

The countries covered in the cardiovascular repair and reconstruction market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the global cardiovascular repair and reconstruction market. Because of the ageing population and bad lifestyle, cardiovascular illnesses are prevalent.

Asia-Pacific is expected to witness the fastest growth over the forecast period. Due to their vast populations, ageing populations, high unmet healthcare requirements, and changing lifestyles, China, India, and other growing nations in the region are at the forefront. Improvements in the region's healthcare infrastructure are also helping to drive the market forward.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Cardiovascular Repair and Reconstruction Market Share Analysis

The cardiovascular repair and reconstruction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiovascular repair and reconstruction market.

Some of the major players operating in the cardiovascular repair and reconstruction market are:

• CryoLife, Inc. (U.S)
• Edwards Lifesciences Corporation (U.S)
• Bard Peripheral Vascular (U.S)
• Baxter (U.S)
• Anteris (U.S)
• Neovasc Inc. (Canada)
• Southernlight Biomaterials (New Zealand)
• Medtronic (Ireland)
• GETINGE AB (Sweden)
• W. L. Gore & Associates, Inc. (U.S)
• Abbott (U.S)
• LeMaitre Vascular Inc. (U.S)
• BioIntegral Surgical (Canada)
• Laboratory Corporation of America Holdings (U.S)
• Terumo Medical Corporation (U.S)
• Perouse Medical (France)
• Gunze Limited (U.S)
• Maverick Biosciences (U.S)